Patterson Companies, Inc. (PDCO) by event type
PDCO moves most on price-target cuts — a median of +0.12% at 30 minutes across 19 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the PDCO overview →
How PDCO reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 989 of 2,283 | 20 | +0.05% | 65% | +0.07% |
| Rating reiterations 1,583 of 3,522 | 25 | 0.00% | 44% | -0.51% |
| Price-target cuts 360 of 1,527 | 19 | +0.12% | 53% | -0.51% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how PDCO usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · Price-target cuts → · PDCO overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GlycoMimetics, Inc. (GLYC) | 144 | +0.53% | 54% |
| Mustang Bio, Inc. (MBIO) | 144 | -0.46% | 41% |
| Propanc Biopharma, Inc. (PPCB) | 144 | 0.00% | 41% |
| Cara Therapeutics, Inc. (CARA) | 143 | -0.56% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.